MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which evaluates the safety and effectiveness ...
A study of a novel percutaneous technique for treating long, complex occlusions of the superficial femoral artery met its primary safety and efficacy endpoints, according to findings presented at the ...
LAS VEGAS, NV—An endovascular approach for the treatment of long, complex superficial femoropopliteal lesions that incorporates surgical principles results in good patency through 3 years with no late ...
BLACKFOOT —Bingham Healthcare is proud to announce that David Shelley MD, a leading vascular specialist, has successfully performed a percutaneous arterial bypass (PTAB) procedure using the innovative ...
Novel technology enables a new, minimally invasive treatment for patients suffering from extremely long peripheral artery blockages LONDON, Aug. 31, 2017 /PRNewswire/ -- Frost & Sullivan is pleased to ...
MILPITAS, Calif.--(BUSINESS WIRE)--PQ Bypass, Inc., a clinical-stage medical device company, today announced it has received full approval of its investigational device exemption (IDE) trial of the ...
LONDON, Aug. 31, 2017 /PRNewswire/ -- Frost & Sullivan is pleased to recognize PQ Bypass with the 2017 European PAD Interventions Technology Innovation Award. PQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results